Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,491 across all filing types
Latest filing 2019-09-30 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Notification Letter to Non-registered Holders and Request Form
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 30 September 2019 from 3SBio Inc. informing non-registered shareholders about the publication of the 2019 Interim Report. It provides instructions on how to access the report online and how to request a printed version by completing a request form. The document does not contain the actual interim report or substantive financial data but serves as a corporate communication to notify shareholders of the report's availability and how to obtain it. The document length is 6175 characters, which is relatively short and consistent with an announcement rather than the full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Interim Report (IR).
2019-09-30 English
Notification Letter to Registered Shareholders and Change Request Form
Report Publication Announcement Classification · 95% confidence The document is a letter to shareholders informing them about the publication of the company's 2019 Interim Report. It provides instructions on how shareholders can access the report electronically or request printed copies. It also includes a Change Request Form for shareholders to specify their preferences for receiving future corporate communications. The document does not contain the actual interim report or substantive financial data but rather serves as a notification and communication regarding the availability of the report. The document length is 8254 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA).
2019-09-30 English
2019 Interim Report
Interim / Quarterly Report Classification · 100% confidence The document is titled '2019 Interim Report' and contains detailed financial highlights, management discussion and analysis, corporate information, and unaudited interim condensed consolidated financial statements. It covers a six-month period ending 30 June 2019, which is typical for an interim or quarterly report. The presence of financial statements and substantive financial data confirms it is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-09-30 English
VOLUNTARY ANNOUNCEMENT - PRODUCT DEVELOPMENT ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding the approval for clinical trials of a drug (oral disintegration tablet of nalfurafine hydrochloride). It is not a financial report, earnings release, or regulatory filing related to financial performance. The document is short (3980 characters) and serves as a business update rather than a formal report. It does not contain financial statements or detailed financial data. It is an announcement of a business development event, specifically a clinical trial approval, which fits best under a general regulatory or business update announcement category. Given the options, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2019-09-18 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/08/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, consistent with a capital/financing update or share capital change disclosure. Given the detailed nature of share capital movements and the monthly reporting frequency, the document best fits the category of Share Issue/Capital Change (SHA).
2019-09-05 English
Memorandum of Association and Bye-laws
Governance Information Classification · 95% confidence The document is a detailed legal and corporate governance text including the Memorandum of Association, Bye-laws, Certificates of Incorporation, and detailed company powers and objects under the Companies Act 1981 of Bermuda. It contains foundational corporate documents and governance structure information rather than financial performance data, earnings, or management commentary. There is no indication of financial statements, audit opinions, earnings releases, or shareholder meeting materials. The content is focused on company formation, legal powers, and governance rules. Therefore, the document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2019-09-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.